Clinical trial registry record

Social Isolation and Aging in Schizophrenia

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated February 19, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07419321
Last registry update
February 19, 2026
Status
Recruiting
Phase
Phase not reported
Sponsor
Icahn School of Medicine at Mount Sinai
Enrollment
650
Countries
United States, Netherlands, Spain, United Kingdom
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
650
Population
ALL · 40 Years to 70 Years
Duration
2024-01-09 to 2027-07-01
Intervention
Comparator
Not reported
Outcomes measured
Occurrence of newly diagnosed conditions — Day 1; Short Form Health Survey (SF-36), — Day 1; Number of Participants with High Cholesterol — Day 1; Number of participants with High Blood Pressure — Day 1; Schedule for Deficit Syndrome (SDS) — Chart Review for the legacy data from when participants were first assessed betwe…; The Birchwood social functioning scale (SFS) — Chart review for the legacy data from when participants were first asses…; 'Social Isolation' subscale of the Structured Interview for Schizotypy-Revised (SIS-R) — Chart review for the legacy da…; The Revised UCLA Loneliness Scale (R-UCLA) — Day 1; Ecological Momentary Assessment (EMA) — Chart review legacy data; and 3 times daily for 14 days; Barriers to Access to Care Evaluation scale (BACE) — Day 1
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Loneliness and ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Title supplies ageing or longevity context.

Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.